Auscann Group Holdings Ltd
Buy, Hold or Sell?
Let's analyse Auscann together
I guess you are interested in Auscann Group Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.
I'm going to help you getting a better view of Auscann Group Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.
You can find me behind Let's Analyse Together in the top-right of each section.
Get notifications about Auscann Group Holdings Ltd
I send you an email if I find something interesting about Auscann Group Holdings Ltd.
Quick analysis of Auscann (30 sec.)
1. Valuation of Auscann (5 min.)
A$0.04
A$0.04
2. Growth of Auscann (5 min.)
3. Financial Health of Auscann (5 min.)
4. Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry (5 min.)
Industry Rankings (Drug Manufacturers-Specialty & Generic)
Fundamentals of Auscann
Financial Health
Compared to previous year | Compared to industry | |
---|---|---|
The company is making a huge loss. | ||
Using its assets, the company is very inefficient in making profit. | ||
Using its investors money, the company is very inefficient in making profit. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is operating very inefficient. | ||
The company is very efficient in keeping operating costs low. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is very able to pay all its short-term debts. | ||
The company is very able to pay all its short-term debts with the most liquid assets. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is very able to pay all its debts by selling its assets. | ||
The company is very able to pay all its debts with equity. |
1.1. Profitability of Auscann Group Holdings Ltd.
1.1. Profitability
1.1.1. Net Profit Margin
- Above 10% is considered healthy but always compare Auscann to the Drug Manufacturers-Specialty & Generic industry mean.
- A Net Profit Margin of -389.4% means that $-3.89 for each $1 in revenue is generated as profit.
Let's take a look of the Net Profit Margin trends of Auscann Group Holdings Ltd:
Trends
- The YOY is -1,114.1%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -48,151.7%. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -24,768.9%. Compared to the 5Y term, the 10Y term is trending down. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | -389.4% | TTM | -3,425.8% | +3,036.4% | |
TTM | -3,425.8% | YOY | -1,114.1% | -2,311.7% | |
TTM | -3,425.8% | 5Y | -48,151.7% | +44,725.9% | |
5Y | -48,151.7% | 10Y | -24,768.9% | -23,382.8% |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Net Profit Margin with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.3%. trending down. -2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.3%. trending down. -2
1.1.2. Return on Assets
- Above 5% is considered healthy but always compare Auscann to the Drug Manufacturers-Specialty & Generic industry mean.
- -7.6% Return on Assets means that Auscann generated $-0.08 profit for each $1 in assets.
Let's take a look of the Return on Assets trends of Auscann Group Holdings Ltd:
Trends
- The YOY is -5.9%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -13.7%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -18.1%. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | -7.6% | TTM | -51.6% | +44.0% | |
TTM | -51.6% | YOY | -5.9% | -45.7% | |
TTM | -51.6% | 5Y | -13.7% | -37.9% | |
5Y | -13.7% | 10Y | -18.1% | +4.4% |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Return on Assets with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is -0.2%. trending down. -2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is -0.3%. trending down. -2
1.1.3. Return on Equity
- Above 15%-20% is considered healthy but always compare Auscann to the Drug Manufacturers-Specialty & Generic industry mean.
- -7.8% Return on Equity means Auscann generated $-0.08 for each $1 the owners (shareholders) invested.
Let's take a look of the Return on Equity trends of Auscann Group Holdings Ltd:
Trends
- The YOY is -6.0%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -14.0%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -50.2%. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | -7.8% | TTM | -52.5% | +44.8% | |
TTM | -52.5% | YOY | -6.0% | -46.5% | |
TTM | -52.5% | 5Y | -14.0% | -38.5% | |
5Y | -14.0% | 10Y | -50.2% | +36.2% |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Return on Equity with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.5%. trending down. -2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.3%. trending down. -2
1.2. Operating Efficiency of Auscann Group Holdings Ltd.
1.2. Operating Efficiency
1.2.1. Operating Margin
- Measures how much profit Auscann makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
- Above 15% is considered healthy but always compare Auscann to the Drug Manufacturers-Specialty & Generic industry mean.
- An Operating Margin of 0.0% means the company generated $0.00 for each $1 in revenue (before taxes).
Let's take a look of the Operating Margin trends of Auscann Group Holdings Ltd:
- The MRQ is 0.0%. The data is not here.
Trends
- The YOY is -600.7%. Compared to the TTM, the mid term is trending up. +2
- The 5Y is -47,404.9%. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -27,394.5%. Compared to the 5Y term, the 10Y term is trending down. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | - | TTM | -104.9% | +104.9% | |
TTM | -104.9% | YOY | -600.7% | +495.8% | |
TTM | -104.9% | 5Y | -47,404.9% | +47,300.0% | |
5Y | -47,404.9% | 10Y | -27,394.5% | -20,010.3% |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Operating Margin with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.5%. trending down. -2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 2.9%. trending down. -2
1.2.2. Operating Ratio
- Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
- An Operation Ratio of 0.06 means that the operating costs are $0.06 for each $1 in net sales.
Let's take a look of the Operating Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is 0.078. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 80.433. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 47.575. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.061 | TTM | 0.057 | +0.003 | |
TTM | 0.057 | YOY | 0.078 | -0.021 | |
TTM | 0.057 | 5Y | 80.433 | -80.375 | |
5Y | 80.433 | 10Y | 47.575 | +32.857 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Operating Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.416. trending down. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.422. trending down. +2
1.3. Liquidity of Auscann Group Holdings Ltd.
1.3. Liquidity
1.3.1. Current Ratio
- Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
- A Current Ratio of 7.27 means the company has $7.27 in assets for each $1 in short-term debts.
Let's take a look of the Current Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is 18.890. Compared to the TTM, the mid term is trending down. -2
- The 5Y is 28.883. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 19.226. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 7.273 | TTM | 18.370 | -11.097 | |
TTM | 18.370 | YOY | 18.890 | -0.520 | |
TTM | 18.370 | 5Y | 28.883 | -10.513 | |
5Y | 28.883 | 10Y | 19.226 | +9.657 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Current Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.778. trending up. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.844. trending up. +2
1.3.2. Quick Ratio
- Above 1 is considered healthy but always compare Auscann to the Drug Manufacturers-Specialty & Generic industry mean.
- A Quick Ratio of 3.73 means the company can pay off $3.73 for each $1 in debt (using most liquid assets).
Let's take a look of the Quick Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is 9.219. Compared to the TTM, the mid term is trending up. +2
- The 5Y is 14.107. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 9.828. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 3.733 | TTM | 10.453 | -6.720 | |
TTM | 10.453 | YOY | 9.219 | +1.234 | |
TTM | 10.453 | 5Y | 14.107 | -3.654 | |
5Y | 14.107 | 10Y | 9.828 | +4.279 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Quick Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.659. trending up. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.806. trending up. +2
1.4. Solvency of Auscann Group Holdings Ltd.
1.3. Liquidity
1.4.1. Debt to Asset Ratio
- Below 1 (100%) is considered healthy but always compare Auscann to Drug Manufacturers-Specialty & Generic industry mean.
- A Debt to Asset Ratio of 0.02 means that Auscann assets are financed with 1.8% credit (debt) and the remaining percentage (100% - 1.8%) is financed by its owners/shareholders.
Let's take a look of the Debt to Asset Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is 0.019. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 0.024. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 0.106. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.018 | TTM | 0.018 | 0.000 | |
TTM | 0.018 | YOY | 0.019 | -0.001 | |
TTM | 0.018 | 5Y | 0.024 | -0.005 | |
5Y | 0.024 | 10Y | 0.106 | -0.082 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Debt to Asset Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.439. trending down. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.425. trending down. +2
1.4.2. Debt to Equity Ratio
- Below 2 is considered healthy but always compare Auscann to the Drug Manufacturers-Specialty & Generic industry mean.
- A Debt to Equity ratio of 1.8% means that company has $0.02 debt for each $1 in shareholders equity.
Let's take a look of the Debt to Equity Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is 0.020. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 0.024. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 0.879. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.018 | TTM | 0.019 | 0.000 | |
TTM | 0.019 | YOY | 0.020 | -0.001 | |
TTM | 0.019 | 5Y | 0.024 | -0.006 | |
5Y | 0.024 | 10Y | 0.879 | -0.855 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Debt to Equity Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.700. trending down. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.704. trending down. +2
2. Market Valuation of Auscann Group Holdings Ltd
2. Earnings Per Share
2.1. Price to Earnings Ratio
- Above 15 is considered overpriced but always compare Auscann to the Drug Manufacturers-Specialty & Generic industry mean.
- A PE ratio of -13.44 means the investor is paying $-13.44 for every $1 in earnings.
Let's take a look of the Price to Earnings Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is -22.279. Compared to the TTM, the mid term is trending up. -2
- The 5Y is -78.734. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is -92.715. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
EOD | -13.438 | MRQ | -13.438 | 0.000 | |
MRQ | -13.438 | TTM | -5.882 | -7.557 | |
TTM | -5.882 | YOY | -22.279 | +16.397 | |
TTM | -5.882 | 5Y | -78.734 | +72.853 | |
5Y | -78.734 | 10Y | -92.715 | +13.981 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Price to Earnings Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is -0.163. trending down. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 0.006. trending down. +2
2.2. Price Earnings to Growth Ratio
- Lower is better.
- A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.
Let's take a look of the Price Earnings to Growth Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is -21.836. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 336,472.424. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 159,347.378. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | -7.141 | TTM | -2.597 | -4.544 | |
TTM | -2.597 | YOY | -21.836 | +19.239 | |
TTM | -2.597 | 5Y | 336,472.424 | -336,475.021 | |
5Y | 336,472.424 | 10Y | 159,347.378 | +177,125.046 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Price Earnings to Growth Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 5.846. trending down. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 12.876. trending down. +2
2. Book Value per Share
2.3. Price to Book Ratio
- At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
- A PB ratio of 1.05 means the investor is paying $1.05 for each $1 in book value.
Let's take a look of the Price to Book Ratio trends of Auscann Group Holdings Ltd:
Trends
- The YOY is 1.232. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 7.115. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 12.878. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
EOD | 1.045 | MRQ | 1.045 | 0.000 | |
MRQ | 1.045 | TTM | 0.899 | +0.146 | |
TTM | 0.899 | YOY | 1.232 | -0.333 | |
TTM | 0.899 | 5Y | 7.115 | -6.216 | |
5Y | 7.115 | 10Y | 12.878 | -5.764 |
Compared to industry (Drug Manufacturers-Specialty & Generic)
Let compare the company's Price to Book Ratio with the average (mean) in the Drug Manufacturers-Specialty & Generic industry:
- The MRQ average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.598. trending down. +2
- The TTM average (mean) in the Drug Manufacturers-Specialty & Generic industry is 1.660. trending down. +2
2. Total Gains per Share
3. Holders & Insider Transactions
Let's take a look at which institutions, funds and insiders are holding shares of Auscann Group Holdings Ltd.
4. Summary
4.1. Key Performance Indicators
The key performance indicators of Auscann Group Holdings Ltd compared to the Most Recent Quarter (MRQ).
End of day | +/- | Most Recent Quarter | Trailing 12 Months | +/- | Year-Over-Year | +/- | 5 Year | +/- | 10 Year | +/- | |
---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Change Per Share | - | - | -0.003 | -0.018 | +502% | 0.006 | -146% | 0.000 | -719% | 0.001 | -430% |
Book Value Growth | - | - | 0.928 | 0.793 | +17% | 1.095 | -15% | 1.083 | -14% | 2.805 | -67% |
Book Value Per Share | - | - | 0.038 | 0.057 | -33% | 0.090 | -57% | 0.077 | -50% | 0.040 | -3% |
Book Value Per Share Growth | - | - | 0.928 | 0.793 | +17% | 1.110 | -16% | 1.084 | -14% | 2.883 | -68% |
Current Ratio | - | - | 7.273 | 18.370 | -60% | 18.890 | -62% | 28.883 | -75% | 19.226 | -62% |
Debt To Asset Ratio | - | - | 0.018 | 0.018 | -1% | 0.019 | -6% | 0.024 | -24% | 0.106 | -83% |
Debt To Equity Ratio | - | - | 0.018 | 0.019 | -2% | 0.020 | -6% | 0.024 | -25% | 0.879 | -98% |
Dividend Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% |
Eps | - | - | -0.003 | -0.018 | +498% | -0.005 | +57% | -0.007 | +137% | -0.004 | +44% |
Eps Growth | - | - | 1.882 | -0.155 | +108% | 1.013 | +86% | 0.754 | +149% | -0.384 | +120% |
Free Cash Flow Per Share | - | - | -0.003 | -0.002 | -50% | -0.003 | -15% | -0.005 | +67% | -0.003 | -10% |
Free Cash Flow Per Share Growth | - | - | -2.073 | 0.215 | -1064% | 1.094 | -289% | 0.842 | -346% | 0.754 | -375% |
Free Cash Flow To Equity Per Share | - | - | -0.003 | -0.002 | -50% | -0.003 | -16% | -0.005 | +64% | -0.003 | -6% |
Free Cash Flow To Equity Per Share Growth | - | - | -2.007 | 0.235 | -954% | 1.094 | -283% | 1.211 | -266% | 0.836 | -340% |
Gross Profit Margin | - | - | 1.000 | 1.000 | 0% | 0.750 | +33% | 0.950 | +5% | 1.005 | -1% |
Intrinsic Value_10Y_max | - | - | 0.009 | - | - | - | - | - | - | - | - |
Intrinsic Value_10Y_min | - | - | -0.371 | - | - | - | - | - | - | - | - |
Intrinsic Value_1Y_max | - | - | -0.005 | - | - | - | - | - | - | - | - |
Intrinsic Value_1Y_min | - | - | -0.020 | - | - | - | - | - | - | - | - |
Intrinsic Value_3Y_max | - | - | -0.011 | - | - | - | - | - | - | - | - |
Intrinsic Value_3Y_min | - | - | -0.076 | - | - | - | - | - | - | - | - |
Intrinsic Value_5Y_max | - | - | -0.011 | - | - | - | - | - | - | - | - |
Intrinsic Value_5Y_min | - | - | -0.148 | - | - | - | - | - | - | - | - |
Net Profit Margin | - | - | -3.894 | -34.258 | +780% | -11.141 | +186% | -481.517 | +12266% | -247.689 | +6261% |
Operating Margin | - | - | - | -1.049 | 0% | -6.007 | 0% | -474.049 | 0% | -273.945 | 0% |
Operating Ratio | - | - | 0.061 | 0.057 | +6% | 0.078 | -22% | 80.433 | -100% | 47.575 | -100% |
Pb Ratio | 1.045 | 0% | 1.045 | 0.899 | +16% | 1.232 | -15% | 7.115 | -85% | 12.878 | -92% |
Pe Ratio | -13.438 | 0% | -13.438 | -5.882 | -56% | -22.279 | +66% | -78.734 | +486% | -92.715 | +590% |
Peg Ratio | - | - | -7.141 | -2.597 | -64% | -21.836 | +206% | 336472.424 | -100% | 159347.378 | -100% |
Price Per Share | 0.040 | 0% | 0.040 | 0.049 | -18% | 0.104 | -61% | 0.366 | -89% | 0.262 | -85% |
Price To Total Gains Ratio | -13.567 | 0% | -13.567 | -7.151 | -47% | -2.946 | -78% | -18631440.741 | +137328750% | -7498992.291 | +55273564% |
Profit Growth | - | - | 1.941 | 0.423 | +359% | 1.162 | +67% | 0.845 | +130% | 0.715 | +171% |
Quick Ratio | - | - | 3.733 | 10.453 | -64% | 9.219 | -60% | 14.107 | -74% | 9.828 | -62% |
Return On Assets | - | - | -0.076 | -0.516 | +576% | -0.059 | -23% | -0.137 | +80% | -0.181 | +137% |
Return On Equity | - | - | -0.078 | -0.525 | +575% | -0.060 | -23% | -0.140 | +80% | -0.502 | +545% |
Revenue Growth | - | - | 1.500 | 0.750 | +100% | - | +100% | 8.383 | -82% | 6.058 | -75% |
Total Gains Per Share | - | - | -0.003 | -0.018 | +502% | 0.006 | -146% | 0.000 | -719% | 0.001 | -430% |
Total Gains Per Share Growth | - | - | 1.941 | 1.971 | -1% | 1.000 | +94% | -132293.244 | +6814314% | -55128.595 | +2839686% |
Usd Book Value | - | - | 11214017.374 | 16708165.900 | -33% | 26512544.636 | -58% | 22657821.910 | -51% | 12150705.202 | -8% |
Usd Book Value Change Per Share | - | - | -0.002 | -0.012 | +502% | 0.004 | -146% | 0.000 | -719% | 0.001 | -430% |
Usd Book Value Per Share | - | - | 0.025 | 0.038 | -33% | 0.060 | -57% | 0.051 | -50% | 0.026 | -3% |
Usd Dividend Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% |
Usd Eps | - | - | -0.002 | -0.012 | +498% | -0.003 | +57% | -0.005 | +137% | -0.003 | +44% |
Usd Free Cash Flow | - | - | -892599.745 | -443622.040 | -50% | -768490.359 | -14% | -1498302.241 | +68% | -849683.187 | -5% |
Usd Free Cash Flow Per Share | - | - | -0.002 | -0.001 | -50% | -0.002 | -15% | -0.003 | +67% | -0.002 | -10% |
Usd Free Cash Flow To Equity Per Share | - | - | -0.002 | -0.001 | -50% | -0.002 | -16% | -0.003 | +64% | -0.002 | -6% |
Usd Price Per Share | 0.027 | 0% | 0.027 | 0.032 | -18% | 0.069 | -61% | 0.243 | -89% | 0.174 | -85% |
Usd Profit | - | - | -872414.543 | -7677095.403 | +780% | -1708945.299 | +96% | -2453451.242 | +181% | -1487556.655 | +71% |
Usd Revenue | - | - | 224046.428 | 124482.065 | +80% | 67088.852 | +234% | 88180.298 | +154% | 51512.797 | +335% |
Usd Total Gains Per Share | - | - | -0.002 | -0.012 | +502% | 0.004 | -146% | 0.000 | -719% | 0.001 | -430% |
EOD | +0 -0 | MRQ | TTM | +21 -17 | YOY | +15 -24 | 5Y | +23 -16 | 10Y | +17 -22 |
4.2. Fundamental Score
Penke's Stock Scanner
Indicator | Condition | Value | ||
---|---|---|---|---|
Price to Earnings Ratio (EOD) | Between | 0-15 | -13.438 | |
Price to Book Ratio (EOD) | Between | 0-1 | 1.045 | |
Net Profit Margin (MRQ) | Greater than | 0 | -3.894 | |
Operating Margin (MRQ) | Greater than | 0 | 0.000 | |
Quick Ratio (MRQ) | Greater than | 1 | 3.733 | |
Current Ratio (MRQ) | Greater than | 1 | 7.273 | |
Debt to Asset Ratio (MRQ) | Less than | 1 | 0.018 | |
Debt to Equity Ratio (MRQ) | Less than | 1 | 0.018 | |
Return on Equity (MRQ) | Greater than | 0.15 | -0.078 | |
Return on Assets (MRQ) | Greater than | 0.05 | -0.076 | |
Total | 4/10 (40.0%) |
4.3. Technical Score
Penke's Symbol Scanner
Indicator | Condition | Value | ||
---|---|---|---|---|
Rsi | Greater than | 50 | 0.000 | |
Ma 20 | Greater than | Ma 50 | 0.040 | |
Ma 50 | Greater than | Ma 100 | 0.040 | |
Ma 100 | Greater than | Ma 200 | 0.040 | |
Open | Greater than | Close | 0.040 | |
Total | 0/5 (0.0%) |
Latest Balance Sheet
Balance Sheet of 2022-12-31. Currency in AUD. All numbers in thousands.
Summary
As reported | |
---|---|
Total Liabilities | 310 |
Total Stockholder Equity | + 16,856 |
Total Assets | = 17,165 |
Assets
Total Current Assets
Long-term Assets
Property Plant Equipment | 32 |
Long-term Assets (as reported) | 0 |
---|---|
Long-term Assets (calculated) | 32 |
+/- | 32 |
Liabilities & Shareholders' Equity
Total Current Liabilities
Total Current Liabilities (as reported) | 310 |
---|---|
Total Current Liabilities (calculated) | 0 |
+/- | 310 |
Long-term Liabilities
Long-term Liabilities (as reported) | 0 |
---|---|
Long-term Liabilities (calculated) | 0 |
+/- | 0 |
Total Stockholder Equity
Common Stock | 93,165 |
Retained Earnings | -76,310 |
Total Stockholder Equity (as reported) | 16,856 |
---|---|
Total Stockholder Equity (calculated) | 16,856 |
+/- | 0 |
Balance Sheet
Currency in AUD. All numbers in thousands.
Trend | 2022-12-31 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 | 2003-06-30 | 2003-03-31 | 2002-12-31 | 2002-09-30 | 2002-06-30 | 2002-03-31 | 2001-12-31 | 2001-09-30 | 2001-06-30 | 2001-03-31 | 2000-12-31 | 2000-09-30 | 2000-06-30 | 2000-03-31 | 1999-12-31 | 1999-09-30 | 1999-06-30 | 1999-03-31 | 1998-12-31 | 1998-09-30 | 1998-06-30 | 1998-03-31 | 1997-12-31 | 1997-09-30 | 1997-06-30 | 1997-03-31 | 1996-12-31 | 1996-09-30 | 1996-06-30 | 1996-03-31 | 1995-12-31 | 1995-09-30 | 1995-06-30 | 1995-03-31 | 1994-12-31 | 1994-09-30 | 1994-06-30 | 1994-03-31 | 1993-12-31 | 1993-09-30 | 1993-06-30 | 1993-03-31 | 1992-12-31 | 1992-09-30 | 1992-06-30 | 1992-03-31 | 1991-12-31 | 1991-09-30 | 1991-06-30 | 1991-03-31 | 1990-12-31 | 1990-09-30 | 1990-06-30 | 1990-03-31 | 1989-12-31 | 1989-09-30 | 1989-06-30 | 1989-03-31 | 1988-12-31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
> Total Assets |
| 17,165 | 18,450 | 0 | 41,191 | 0 | 45,119 | 0 | 30,989 | 0 | 35,465 | 0 | 39,354 | 39,354 | 42,868 | 42,868 | 43,849 | 43,849 | 14,712 | 14,712 | 13,175 | 13,175 | 15,799 | 15,799 | 4,900 | 4,900 | 381 | 381 | 867 | 867 | 389 | 389 | 521 | 521 | 805 | 805 | 1,056 | 1,056 | 1,428 | 1,429 | 1,556 | 1,556 | 1,326 | 1,326 | 1,436 | 1,436 | 335 | 335 | 27 | 27 | 8,265 | 8,265 | 7,770 | 7,770 | 37,420 | 37,420 | 44,216 | 44,216 | 106,195 | 106,195 | 90,915 | 90,915 | 97,201 | 101,786 | 55,474 | 55,474 | 58,126 | 58,126 | 71,162 | 71,162 | 68,801 | 69,012 | 58,420 | 58,420 | 55,044 | 55,044 | 46,887 | 46,887 | 40,532 | 40,532 | 36,799 | 36,799 | 34,897 | 34,897 | 20,540 | 20,540 | 1,606 | 1,605 | 1,618 | 1,618 | 1,741 | 1,740 | 0 | 0 | 1,830 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,586 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
> Total Current Assets |
| 2,253 | 7,073 | 7,073 | 12,167 | 12,167 | 15,230 | 15,230 | 19,349 | 19,349 | 23,642 | 23,642 | 27,924 | 27,924 | 35,675 | 35,675 | 43,448 | 43,448 | 13,906 | 13,906 | 12,816 | 12,816 | 15,218 | 0 | 0 | 0 | 381 | 2,978 | 0 | 0 | 389 | 0 | 0 | 0 | 804 | 0 | 0 | 0 | 1,426 | 0 | 0 | 0 | 1,326 | 0 | 0 | 0 | 335 | 0 | 0 | 0 | 7,680 | 0 | 0 | 0 | 13,020 | 0 | 0 | 0 | 35,099 | 0 | 0 | 0 | 18,674 | 0 | 0 | 0 | 13,082 | 0 | 0 | 0 | 17,108 | 0 | 0 | 0 | 12,123 | 0 | 0 | 0 | 8,052 | 0 | 0 | 0 | 6,610 | 0 | 0 | 0 | 1,606 | 0 | 0 | 0 | 1,741 | 0 | 0 | 0 | 1,830 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,586 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash And Cash Equivalents |
| 599 | 5,717 | 0 | 11,399 | 0 | 13,680 | 0 | 15,234 | 0 | 19,166 | 0 | 26,078 | 26,078 | 35,307 | 35,307 | 41,744 | 41,744 | 12,878 | 12,878 | 12,290 | 12,290 | 15,077 | 0 | 0 | 0 | 370 | 2,961 | 0 | 0 | 376 | 0 | 0 | 0 | 785 | 0 | 0 | 0 | 1,388 | 0 | 0 | 0 | 1,317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73 | 0 | 0 | 0 | 104 | 0 | 0 | 0 | 3,574 | 0 | 0 | 0 | 807 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 405 | 0 | 0 | 0 | 143 | 0 | 0 | 0 | 884 | 0 | 0 | 0 | 987 | 0 | 0 | 0 | 251 | 0 | 0 | 0 | 254 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 224 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term Investments |
| 42 | 42 | 0 | 12 | 0 | 162 | 0 | 217 | 0 | 135 | 0 | 135 | 135 | 135 | 135 | 135 | 135 | 134 | 134 | 123 | 123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 591 | 0 | 0 | 0 | 1,433 | 0 | 0 | 0 | 1,563 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,354 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Receivables |
| 473 | 1,205 | 1,205 | 268 | 0 | 205 | 959 | 177 | 177 | 8 | 0 | 451 | 451 | 129 | 129 | 560 | 560 | 707 | 819 | 352 | 352 | 139 | 139 | 28 | 28 | 10 | 10 | 11 | 11 | 13 | 13 | 25 | 25 | 19 | 19 | 50 | 50 | 23 | 23 | 51 | 51 | 8 | 8 | 22 | 22 | 0 | 0 | 23 | 23 | 20 | 20 | 19 | 19 | 3,123 | 3,123 | 5,921 | 5,921 | 21,189 | 21,189 | 6,936 | 6,936 | 11,079 | 11,339 | 4,820 | 4,820 | 6,135 | 6,855 | 7,163 | 7,163 | 5,777 | 3,336 | 4,814 | 4,814 | 3,272 | 3,723 | 4,079 | 4,079 | 2,571 | 2,571 | 2,707 | 2,707 | 1,813 | 1,813 | 19 | 19 | 16 | 16 | 18 | 18 | 49 | 49 | 0 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Current Assets |
| 0 | 1,247 | 0 | 555 | 555 | 1,131 | 1,337 | 400 | 400 | 726 | 869 | 659 | 659 | 104 | 367 | 1,704 | 0 | 320 | 74 | 526 | 51 | 141 | 2 | 4,836 | 4,836 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 15 | 15 | 13 | 13 | 0 | 0 | 0 | 0 | 335 | 335 | 0 | 0 | 7,587 | 7,587 | 7,141 | 7,141 | 77 | 76 | 26 | 26 | 5 | 5 | 751 | 751 | 373 | 113 | 525 | 525 | 996 | 276 | 1,354 | 1,354 | 454 | 2,891 | 333 | 333 | 565 | 114 | 318 | 318 | 357 | 357 | 404 | 404 | 153 | 153 | 20 | 20 | 11 | 11 | 18 | 18 | 7 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
> Long-term Assets |
| 0 | 11,377 | 0 | 0 | 0 | 29,890 | 0 | 0 | 0 | 11,823 | 0 | 0 | 0 | 7,193 | 0 | 0 | 0 | 806 | 0 | 0 | 0 | 581 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 585 | 0 | 0 | 0 | 24,400 | 0 | 0 | 0 | 71,096 | 0 | 0 | 0 | 78,527 | 0 | 0 | 0 | 45,044 | 0 | 0 | 0 | 51,693 | 0 | 0 | 0 | 42,921 | 0 | 0 | 0 | 32,480 | 0 | 0 | 0 | 28,287 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property Plant Equipment |
| 32 | 62 | 7,262 | 11,907 | 11,907 | 939 | 12,050 | 11,640 | 11,640 | 11,823 | 11,823 | 11,430 | 11,430 | 7,193 | 7,193 | 301 | 301 | 110 | 110 | 119 | 119 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 585 | 585 | 585 | 585 | 17,400 | 17,400 | 17,773 | 17,773 | 18,592 | 18,592 | 18,963 | 18,963 | 18,628 | 18,628 | 14,566 | 14,566 | 8,148 | 14,702 | 17,578 | 17,578 | 8,621 | 17,685 | 17,748 | 17,748 | 8,385 | 15,116 | 16,242 | 16,242 | 6,209 | 10,160 | 8,128 | 8,128 | 2,969 | 6,920 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29,825 | 29,825 | 29,671 | 29,671 | 29,258 | 34,722 | 0 | 0 | 5,091 | 5,091 | 0 | 0 | 4,807 | 0 | 0 | 0 | 4,224 | 4,414 | 0 | 0 | 3,727 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long Term Investments |
| 0 | 7,200 | 0 | 0 | 0 | 11,111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 696 | 696 | 239 | 239 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets |
| 0 | 0 | 0 | 16,248 | 0 | 17,038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,000 | 7,000 | 7,100 | 7,100 | 19,019 | 48,844 | 52,362 | 52,362 | 22,691 | 57,413 | 27,782 | 27,782 | 22,691 | 27,782 | 27,786 | 27,786 | 22,760 | 27,782 | 22,336 | 22,336 | 18,269 | 22,380 | 18,038 | 18,038 | 14,456 | 18,183 | 18,329 | 18,329 | 18,474 | 18,474 | 617 | 617 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Assets |
| 0 | 4,115 | 4,115 | 869 | 869 | 801 | 801 | 0 | 0 | 0 | 0 | 104 | 104 | 0 | 0 | 100 | 100 | 697 | 697 | 239 | 239 | 581 | 581 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,001 | 7,001 | 7,100 | 7,100 | 52,504 | 52,504 | 58,541 | 58,541 | 59,899 | 64,484 | 32,173 | 32,173 | 30,342 | 30,342 | 32,545 | 32,545 | 34,008 | 34,223 | 27,302 | 27,302 | 27,805 | 27,805 | 20,632 | 20,632 | 22,320 | 22,320 | 21,129 | 21,129 | 25,318 | 21,367 | 617 | 617 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
> Total Liabilities |
| 310 | 296 | 0 | 860 | 0 | 692 | 0 | 773 | 0 | 829 | 0 | 1,097 | 1,097 | 1,199 | 1,199 | 593 | 593 | 600 | 600 | 305 | 305 | 784 | 784 | 5,114 | 5,114 | 61 | 61 | 61 | 61 | 29 | 29 | 35 | 35 | 188 | 188 | 85 | 85 | 58 | 58 | 41 | 41 | 37 | 37 | 35 | 35 | 13,752 | 13,752 | 17,545 | 17,545 | 29,558 | 29,558 | 29,356 | 29,356 | 30,409 | 30,409 | 35,695 | 35,695 | 40,931 | 40,931 | 25,537 | 25,537 | 36,401 | 34,986 | 20,509 | 20,509 | 23,274 | 23,274 | 26,067 | 26,067 | 24,741 | 24,738 | 14,891 | 14,891 | 13,413 | 13,413 | 11,233 | 11,233 | 11,267 | 11,267 | 9,091 | 9,091 | 8,827 | 8,827 | 18,940 | 18,940 | 10 | 10 | 11 | 11 | 18 | 18 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
> Total Current Liabilities |
| 310 | 296 | 296 | 844 | 844 | 652 | 652 | 773 | 773 | 775 | 775 | 1,022 | 1,022 | 1,199 | 1,199 | 593 | 593 | 600 | 600 | 305 | 305 | 784 | 784 | 5,114 | 5,114 | 61 | 61 | 61 | 61 | 29 | 29 | 35 | 35 | 188 | 188 | 85 | 85 | 58 | 58 | 41 | 41 | 37 | 37 | 35 | 35 | 13,752 | 13,752 | 17,545 | 17,545 | 29,558 | 29,558 | 29,356 | 29,356 | 28,409 | 28,409 | 34,628 | 34,628 | 30,691 | 30,691 | 11,849 | 11,849 | 17,092 | 34,953 | 20,509 | 20,509 | 21,446 | 21,946 | 15,473 | 15,473 | 13,122 | 13,122 | 10,304 | 10,304 | 6,380 | 6,380 | 7,702 | 7,702 | 7,326 | 7,326 | 6,709 | 6,709 | 7,160 | 7,160 | 18,940 | 18,940 | 10 | 10 | 11 | 11 | 18 | 18 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term Debt |
| 0 | 40 | 0 | 0 | 0 | 45 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | 135 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,108 | 0 | 0 | 0 | 18,762 | 0 | 0 | 0 | 18,278 | 0 | 0 | 0 | 13,712 | 0 | 0 | 0 | 2,575 | 0 | 0 | 0 | 17,682 | 0 | 0 | 0 | 10,233 | 0 | 0 | 0 | 4,270 | 0 | 0 | 0 | 4,136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 591 | 0 | 0 | 0 | 1,433 | 0 | 0 | 0 | 1,563 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,354 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts payable |
| 0 | 113 | 113 | 600 | 600 | 366 | 366 | 250 | 250 | 497 | 497 | 741 | 741 | 1,026 | 1,026 | 428 | 428 | 472 | 472 | 179 | 179 | 653 | 653 | 297 | 297 | 39 | 39 | 54 | 54 | 21 | 21 | 29 | 29 | 50 | 50 | 62 | 62 | 10 | 10 | 41 | 41 | 4 | 4 | 35 | 35 | 0 | 0 | 1,392 | 1,392 | 0 | 0 | 2 | 2 | 8,029 | 8,029 | 11,572 | 11,572 | 14,808 | 14,808 | 6,881 | 6,881 | 9,821 | 6,090 | 2,631 | 2,631 | 3,369 | 3,369 | 5,026 | 5,026 | 2,537 | 2,537 | 0 | 0 | 1,576 | 1,576 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 11 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Current Liabilities |
| 0 | 143 | 19 | 65 | 65 | 240 | 101 | 411 | 411 | 238 | 98 | 109 | 109 | 173 | 84 | 77 | 77 | 128 | 63 | 126 | 126 | 131 | 132 | 4,817 | 4,817 | 22 | 22 | 7 | 7 | 9 | 9 | 6 | 6 | 138 | 138 | 23 | 23 | 48 | 48 | 0 | 0 | 33 | 33 | 0 | 0 | 1,644 | 1,645 | 0 | 0 | 10,796 | 10,796 | 10,713 | 10,713 | 2,102 | 2,102 | 1,785 | 1,785 | 2,171 | 2,171 | 1,713 | 1,713 | 4,696 | 9,942 | 67 | 67 | 395 | 395 | 347 | 347 | 352 | 352 | 2,207 | 2,207 | 505 | 534 | 3,422 | 3,422 | 1,399 | 3,190 | 2,974 | 2,974 | 1,020 | 6,640 | 18,940 | 18,940 | -591 | 10 | 0 | 0 | -1,433 | 18 | 0 | 0 | -1,554 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,271 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
> Long-term Liabilities |
| 0 | 153 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | 54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 0 | 0 | 0 | 10,240 | 0 | 0 | 0 | 19,309 | 0 | 0 | 0 | 1,828 | 0 | 0 | 0 | 11,619 | 0 | 0 | 0 | 7,033 | 0 | 0 | 0 | 3,941 | 0 | 0 | 0 | 1,667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long term Debt Total |
| 0 | 0 | 0 | 16 | 0 | 40 | 0 | 0 | 0 | 54 | 0 | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 2,000 | 1,067 | 1,067 | 29 | 29 | 2,967 | 2,967 | 2,963 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,022 | 1,022 | 0 | 0 | 0 | 0 | 0 | 0 | 739 | 739 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
> Total Stockholder Equity |
| 16,856 | 18,154 | 0 | 40,331 | 0 | 44,428 | 0 | 30,215 | 0 | 34,636 | 0 | 38,257 | 38,257 | 41,668 | 41,668 | 43,256 | 43,256 | 14,112 | 14,112 | 12,870 | 12,870 | 15,015 | 15,015 | 0 | 0 | 320 | 320 | 806 | 806 | 360 | 360 | 487 | 487 | 617 | 617 | 971 | 971 | 1,370 | 1,370 | 1,514 | 1,514 | 1,288 | 1,288 | 1,401 | 1,401 | -13,417 | 0 | 0 | 0 | -21,293 | 0 | 0 | 0 | 7,011 | 7,011 | 8,521 | 8,521 | 65,264 | 65,264 | 65,378 | 65,378 | 60,800 | 66,800 | 34,965 | 34,965 | 34,852 | 34,852 | 45,095 | 45,095 | 44,060 | 44,274 | 43,529 | 43,529 | 41,631 | 41,631 | 35,654 | 35,654 | 29,265 | 29,265 | 27,708 | 27,708 | 26,070 | 26,070 | 1,601 | 1,601 | 1,595 | 1,595 | 1,607 | 1,607 | 1,722 | 1,722 | 0 | 0 | 1,812 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,446 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
| 93,165 | 93,165 | 93,165 | 93,165 | 93,165 | 93,165 | 93,165 | 75,469 | 75,469 | 75,469 | 75,469 | 75,469 | 75,469 | 75,452 | 75,452 | 72,949 | 72,949 | 39,328 | 39,328 | 33,520 | 33,520 | 33,520 | 33,520 | 81,099 | 81,099 | 81,099 | 81,099 | 81,099 | 81,099 | 80,486 | 80,486 | 80,486 | 80,486 | 80,486 | 80,486 | 80,486 | 80,486 | 80,486 | 80,486 | 80,466 | 80,466 | 79,987 | 79,987 | 79,987 | 79,987 | 77,120 | 77,120 | 76,729 | 76,729 | 76,728 | 76,729 | 76,729 | 76,729 | 76,729 | 76,729 | 68,394 | 68,394 | 74,394 | 68,394 | 68,461 | 68,461 | 68,003 | 62,003 | 38,423 | 38,423 | 38,423 | 38,423 | 38,423 | 38,423 | 38,174 | 38,124 | 38,174 | 38,174 | 36,321 | 36,321 | 31,650 | 31,650 | 25,796 | 25,796 | 25,795 | 25,795 | 25,702 | 25,702 | 2,478 | 2,478 | 2,478 | 2,478 | 2,478 | 2,478 | 2,478 | 2,478 | 0 | 0 | 2,474 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retained Earnings Total Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income |
| 0 | 128 | 0 | 0 | 0 | 786 | 0 | 0 | 0 | 1,273 | 0 | 0 | 0 | 1,237 | 0 | 0 | 0 | 2,156 | 0 | 0 | 0 | 1,199 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,706 | 0 | 0 | 0 | 118 | 0 | 0 | 0 | 56 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | -1,610 | 0 | 0 | 0 | -1,233 | 0 | 0 | 0 | -731 | 0 | 0 | 0 | -324 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital Surplus | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Stockholders Equity |
| 0 | 128 | 128 | 608 | 608 | 786 | 786 | 226 | 226 | 1,453 | 1,273 | 1,241 | 1,241 | 1,325 | 1,237 | 2,118 | 2,118 | 2,156 | 2,156 | 3,884 | 3,884 | 1,199 | 0 | 0 | 0 | 3,574 | 3,574 | 0 | 0 | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,706 | 0 | 0 | 0 | 3,254 | 0 | 0 | 0 | 2,460 | 0 | 0 | 0 | 776 | 0 | 0 | 0 | 1,610 | 0 | 0 | 0 | 1,233 | 0 | 0 | 0 | 731 | 0 | 0 | 0 | 324 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 410 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Balance Sheet
Currency in AUD. All numbers in thousands.